Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

Pharma Tech

AbbVie inks $757m migraine-focused deal with Brise Pharmaceuticals

Nov 3, 2026, 2:21 PM

Read Full Article → AbbVie inks $757m migraine-focused deal with Brise Pharmaceuticals

AbbVie inks $757m migraine-focused deal with Brise Pharmaceuticals

Translate article text

Choose a language and wait for the translated text.

AbbVie and Brise have shared details on this migraine deal two years after the pair originally forged it.

AbbVie inks $757m migraine-focused deal with Brise Pharmaceuticals | PharmaVoice